Simple breath test may predict COPD Flare-Ups
NCT ID NCT07045948
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 100 adults with COPD for one year to see how airway inflammation changes over time. Researchers use a simple breath test (FeNO) and a blood sample to measure inflammation markers. Participants visit the clinic three times—at the start, 6 months, and 12 months—to track lung function and symptoms. The goal is to understand why some people have flare-ups while others stay stable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict COPD flare-ups by monitoring simple breath and blood markers.
- What could go wrong
- This is an observational study with no treatment being tested, so it won't directly improve health. Results may not apply to all COPD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitair Ziekenhuis Brussel
RECRUITINGJette, 1090, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may curb antibiotic overuse in COPD attacks
- Can pressurized breathing boost mucus clearance in lung disease?
- HIV and hidden health risks: a major study probes the link
- Can tracking early COPD reveal ways to halt its progression?
- Smart inhaler coach: can an app perfect your breathing technique?
- Could everyday supplements shield your lungs?